publication date: Oct. 22, 2010

In this issue:
• IOM Review Of Duke Genomics Trials To Focus On Validation, Scientific Criteria • NCI Sends A Second Letter To Groups About Carboplatin • Agency Asks GnRH Sponsors To Add Warnings On Labels • NCI Awards STRAP Grant Of $2 Million To MSKCC  • Beth Israel Suspends Enrollment In Trials Following An Audit • NCCN Guidelines Retain Avastin For Breast Cancer • FDA Approves Herceptin For HER2+ Metastatic Stomach Cancers • “Dollars For Docs” Database Of Pharma Payments Posted By News Organization
Download PDF

To access this members-only content, please log in.
Institutional subscribers, please log in with your IP.
If you're not a subscriber why not join today?
To gain access to the members only content click here to subscribe.
You will be given immediate access to premium content on the site.
Click here to join.

Copyright (c) 2020 The Cancer Letter Inc.